中国保健营养2016，Vol.26Issue(23)：97-97,98,2.
玻璃体腔注射康柏西普治疗糖尿病性黄斑水肿疗效观察
吴晓红 1招志毅1
作者信息
- 1. 广西医科大学第四附属医院 广西柳州 545001
- 折叠
摘要
Abstract
Objective This study was to evaluate the eefficacy of Conbercept on diabetic macular edema.Methods Retrospective analysis of 21 cases (25) to accept the conbercept 0.5mg intravitreal treatment of patients with DME, compare changes before the treatment and after treatment on the best corrected visual acuity (BCVA)and the central macular thickness(CMT).RsultsTheBCVA was improved significantly after treatment,The man central macular thickness was(529.35±158.15)μm in preinjection and (368.50±151.43)μm in postinjection,showing a statisticaly significant difference between them(t=4.518,P=0.000).ConclusionThe intravitreal injection of conbercept can relieve macular edema and damage of visual function,with no significant adverse reactions.关键词
康博西普/糖尿病视网膜病变/黄斑水肿Key words
Conbercept/diabetic retinopathy/macular edema引用本文复制引用
吴晓红,招志毅..玻璃体腔注射康柏西普治疗糖尿病性黄斑水肿疗效观察[J].中国保健营养,2016,26(23):97-97,98,2.
